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METHODOLOGY
New molecular settings to support 
in vivo anti‑malarial assays
Noemí Bahamontes‑Rosa*, Ane Rodriguez Alejandre, Vanesa Gomez, Sara Viera, María G. Gomez‑Lorenzo, 
Laura María Sanz‑Alonso and Alfonso Mendoza‑Losana
Abstract 
Background: Quantitative real‑time PCR (qPCR) is now commonly used as a method to confirm diagnosis of malaria 
and to differentiate recrudescence from re‑infection, especially in clinical trials and in reference laboratories where 
precise quantification is critical. Although anti‑malarial drug discovery is based on in vivo murine efficacy models, use 
of molecular analysis has been limited. The aim of this study was to develop qPCR as a valid methodology to sup‑
port pre‑clinical anti‑malarial models by using filter papers to maintain material for qPCR and to compare this with 
traditional methods.
Methods: FTA technology (Whatman) is a rapid and safe method for extracting nucleic acids from blood. Peripheral 
blood samples from mice infected with Plasmodium berghei, P. yoelii, or P. falciparum were kept as frozen samples or 
as spots on FTA cards. The extracted genetic material from both types of samples was assessed for quantification by 
qPCR using sets of specific primers specifically designed for Plasmodium 18S rRNA, LDH, and CytB genes.
Results: The optimal conditions for nucleic acid extraction from FTA cards and qPCR amplification were set up, and 
were confirmed to be suitable for parasite quantification using DNA as template after storage at room temperature for 
as long as 26 months in the case of P. berghei samples and 52 months for P. falciparum and P. yoelii. The quality of DNA 
extracted from the FTA cards for gene sequencing and microsatellite amplification was also assessed.
Conclusions: This is the first study to report the suitability of FTA cards and qPCR assay to quantify parasite load in 
samples from in vivo efficacy models to support the drug discovery process.
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Background
In anti-malarial clinical trials discerning between mixed 
infections, resistance, re-infection and recrudescence, 
is crucial to establish the efficacy of new anti-malarials. 
The World Health Organization highly recommends the 
use of molecular analysis techniques, like PCR, to assist 
in distinguishing recrudescence from re-infection [1], 
and several methods have been implemented so far for 
this purpose [2]. In clinical trials, a cheap and long-term 
storage method is used for biological samples. The FTA 
technology (Whatman) consists of index-sized cards 
developed for collection and storage of organic samples 
from field isolates. FTA cards are routinely used to sup-
port clinical trials because they are safe and easy to trans-
port at room temperature between laboratories, and the 
genetic material of the parasite remains unchanged in 
the spot sample for long-term storage [3, 4]. However, no 
research has been performed so far to translate the use of 
this technique to mouse malaria models. In drug discov-
ery, the most common murine Plasmodium species used 
are Plasmodium berghei and P. yoelii and, a closer subro-
gate for human parasite infection, the humanized mouse 
model with P. falciparum [5–7].
Among molecular detection techniques, quantitative 
real-time PCR (qPCR) has demonstrated a high sensi-
tivity for detection of low parasite burdens, and is now 
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commonly used as a method to confirm diagnosis of 
malaria, especially in clinical trials and in reference labo-
ratories where precise quantification is critical [8–10]. 
This is the first study to report parasite identification 
and quantification using FTA blood spots to support 
pre-clinical animal models. It was designed to identify 
the adequate molecular settings that may be encoun-




The Plasmodium species tested as tool organisms for 
drug screening were the human pathogen P. falciparum 
and the mouse malaria parasite species P. yoelii and P. 
berghei.
Plasmodium falciparum Pf3D70087/N9 was maintained 
continuously in  vivo in non-myelodepleted NOD-scid 
IL2R gamma-null mice obtained from Charles River Lab-
oratories, engrafted with human erythrocytes [5]. Plas-
modium yoelii and P. berghei were maintained by in vivo 
passage on CD1 mice purchased from Harlan Laborato-
ries. Parasitaemia from mouse malaria models was rou-
tinely monitored on peripheral blood by flow cytometry 
[11]. Protocols were approved by the DDW Ethical Com-
mittee on Animal Research, performed at the DDW Lab-
oratory Animal Science facilities accredited by AAALAC, 
and conducted according to European Union regula-
tions and GlaxoSmithKline policy on the care and use of 
animals.
Biological material
Plasmodium falciparum-infected blood samples were 
taken from the tail vein of the NOD-scid IL2R gamma-
null engrafted mice, and blood samples infected with P. 
berghei or P. yoelii were taken from CD1 mice. Parasitae-
mia was measured by flow cytometry. To establish the 
limit of detection (LOD), P. falciparum blood samples 
were serially diluted tenfold using fresh AB+ human 
erythrocyte concentrates generously donated by the 
Spanish Red Cross blood bank, and P. berghei and P. yoelii 
blood samples were diluted with uninfected blood from 
a donor CD1 mouse. Non-infected human RBC samples 
were included as negative controls for P. falciparum sam-
ples, and mouse blood samples as negative controls for P. 
berghei and P. yoelii. Fifty µl from all samples were imme-
diately stored at −80 °C, and 20 µl spotted onto an FTA 
card (GE Healthcare), dried for 3 h at room temperature 
(RT), and stored at RT from 1 day up to 26 months for P. 
berghei samples and for 52 months for P. yoelii and P. fal-
ciparum for further DNA extraction. The lowest concen-
tration of DNA that tested positive in all replicates was 
considered the LOD.
DNA extraction
To extract DNA, the DNeasy Blood and Tissue Kit (Qia-
gen) was used. For frozen samples, the manufacturer rec-
ommendations were followed. For DNA isolation from the 
FTA cards, the complete disk was punched out from each 
filter paper and incubated with the lysis buffer provided by 
the manufacturer at 56 °C for 1 h, followed by incubation 
for 10 min at 70  °C in shaking conditions. Lysed infected 
red blood cells (iRBC) were then placed onto the purifica-
tion column provided, and purification continued accord-
ing to the standard protocol suggested by the manufacturer.
Genes used
The Plasmodium 18S ribosomal RNA (18S rRNA), lac-
tate dehydrogenase (LDH), and cytochrome B (CytB) 
genes chosen for the study encode highly conserved pro-
teins and are considered as housekeeping genes in detec-
tion and quantification studies [12–14]. Gene sequences 
were retrieved from PlasmoDB and used as templates to 
design qPCR primers using Primer Express Software v.1.5 
(Applied Biosystems). Primer sequences are described in 
Table  1. Primers already reported in the literature for P. 
falciparum LDH, P. yoelii 18S rRNA, and P. berghei LDH 
and CytB primers were also used in this study [12–15].
Quantitative real‑time PCR
Quantitative real-time PCR was performed using an ABI 
PRISM 7500 fast sequence detection system (Applied 
Table 1 Genes and primer sequence
LDH lactate deshydrogenase, CytB cytochrome b
P. falciparum














18S rRNA Pb_18S rRNA‑F: AAGCATTAAATAAAGCGAATACATCCTTAC
Pb_18S rRNA‑R: GGAGATTGGTTTTGACGTTTATGTG
LDH [15] Pb_LDH‑F: GGAAGGAGGTTCACAAGCAGGT
Pb_LDH‑R: TATGCTCTCAGCCAAGTCTGCC
CytB [14] Pb_CytB‑F: TGGGGACAAATGAGTTACTGG
Pb_CytB‑R: CAGTGTATCCTCCACATAACCAA
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Biosystems). Reagents used included Sybr green Jump-
Start Taq ReadyMix (Sigma); 250  nM forward primer; 
250 nM reverse primer; and distilled sterile water up to 
a total reaction volume of 13 + 2 μl of the genetic mate-
rial. Reaction mixtures were prepared at RT in a 96-well 
optical reaction plate (Applied Biosystems) covered with 
optical adhesive covers (Applied Biosystems). The ther-
mal cycling conditions were 50  °C for 2  min, 95  °C for 
10  min and 40 cycles of 95  °C for 15  s and 60  °C for 1 
min. Amplification of each gene was done in duplicate, 
and the average value was taken as the result. Ct values 
are inversely proportional to the amount of template in 
the sample and were used to quantify the relative amount 
of target PCR product present in each reaction. Only 
duplicate Ct values with standard deviation within ±1.5 
Ct were accepted. All qPCR assays were run including the 
Non-Template Control (NTC), and melting curve analy-
sis was always performed at the end of each assay as a 
specificity control.
Parasite genotyping
Genotyping of P. falciparum Pf3D70087/N9 strain was done 
by amplification of the microsatellite regions from DNA 
extracted from the FTA cards. The technique, based on 
the multiple and species-specific repetition of micro-
satellite sequences, was described by Su et  al. in 1998 
using specific primers labeled with FAM (FFF: TAACGT 
TACATTATGTTTTA-FAM and FFR: ATATGGTAT 
TGCGCTTTTA) [16].
Amplification and sequencing of P. falciparum CytB gene
The protocol used was an adaptation from the one 
reported by Korsinczky et  al. [17]. The CytB gene was 
amplified from DNA extracted from the FTA cards using 
primers F CYTB and R CYTB that anneal outside the 
ORF (primer sequences in Table 2). PCR was performed 
using 2 µl of DNA as template. PCR products were puri-
fied and then sequenced using the ABI Prism Big-Dye 
Terminator kit (Applied Biosystems). Nine internal prim-
ers (forward and reverse) were then used to sequence the 
amplified products (Table 2).
Results
Suitability of FTA for in vivo anti‑malarial studies
The value of FTA cards for collecting and storing sam-
ples from in  vivo animal anti-malarial studies was 
assessed. DNA from the filter papers were recoverd 
using a silica-membrane-based column method. Opti-
mal DNA yield and quality for direct qPCR analysis 
was obtained following the protocol described here. In 
order to further assess the quality of the nucleic acids 
extracted from FTA cards, the species-specific repetition 
of microsatellite was successfully amplified, giving the 
same pattern as previously reported for the P. falcipa-
rum strain used in the mouse model (Fig. 1a) [18]. Using 
the same extracted genetic material, the Pf CytB gene 
was sequenced, finding no mutations as compared to 
the CytB 3D7 P. falciparum genome sequence M76611 
(PlasmoDB). The peaks from the electropherograms 
were single and clear for each nucleotide without uncer-
tainty, with a low background line (Fig. 1b). These results 
showed that the extracted genetic material had enough 
quality to support identification of specific resistance 
determinants in long DNA stretches or to assess identifi-
cation of mixed infections.
qPCR setup conditions
The optimal qPCR amplification conditions were set up 
using DNA obtained from tenfold serial fresh blood sam-
ples diluted with human erythrocyte concentrates for 
P. falciparum and with uninfected blood from a donor 
mouse for P. berghei and P. yoelii. Each assay was per-
formed in duplicate, and efficiency of amplification with 
the primer sets was calculated. A linear regression plot 
was generated and the slope, Y-intercept, and r2 value 
were calculated. Data shown in Table  3 confirm that all 
primers showed suitable conditions for parasite quanti-
fication and efficiencies ranging from 94.88 to 50.46  %, 
with r2 ranging from 0.99 to 0.92.
Parasite LOD calculation by qPCR
For parasite detection, LDH, 18S rRNA, and CytB genes 
were evaluated using the corresponding strain-specific 
primers shown in Table  1. The LOD of the qPCR assay 
was determined from DNA extracted from frozen blood 
samples and embedded in FTA cards. All assays were 
performed in duplicate, and the LOD was established 
as the highest Ct value at which the lowest parasite 
Table 2 Primer for  amplification and  sequencing of  the P. 
falciparum CytB gene
Primer for amplification
 F CYTB CCTGATTATCCAGACGCTTTAAATGG
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concentration was detected and expressed as log10 para-
sites/µl. Only Ct values below 40 and duplicate Ct values 
with standard deviation within ±1.5 Ct were considered. 
The mean LOD values are given in Table  4 and varied 
depending on the source and genes used. Assay fluctua-
tion included variation in both nucleic acid extraction 
and amplification. DNA from FTA cards was successfully 
obtained and even a parasite burden lower than one par-
asite/µl (negative log10 parasites/µl) was detected with P. 
falciparum CytB gene. Similar detections were obtained 
in P. berghei with the CytB and 18S rRNA genes and in P. 
yoelii with the 18S rRNA gene. When LOD values were 
compared between frozen samples and FTA cards, a 
lower detection limit was seen for the CytB gene in sam-
ples stored in filter paper. For frozen samples, higher sen-
sitivity was seen for the LDH and 18S rRNA genes.
FTA long‑term storage
The suitability of FTA cards for long-term storage of 
in vivo samples was addressed. FTA cards with Plasmo-
dium samples were stored before DNA extraction at RT 
and protected from light and humidity for 52  months 
for P. yoelii and P. falciparum samples and for 26 months 
for P. berghei. The LOD (log10  parasites/µl) achieved in 
these cards using the CytB gene was 3.8 for P. yoelii, 3.2 
for P. falciparum, and 1.3 for P. berghei. Figure  2 shows 
the correlation of the Ct values obtained from DNA 
extracted from FTA cards stored and from samples pro-
cessed directly after FTA embedding without storage. P. 
yoelii and P. falciparum Ct values were similar at high 
parasitaemia levels or Ct under 24 and 26 respectively. 
For P. berghei, a linear correlation existed in all samples 
tested. The DNA yielded from the FTA cards stored met 
the quality requirements for qPCR, but rendered a lower 
LOD than the ones recently embedded.
Fig. 1 Assessment of the quality of the nucleic acids extracted from FTA cards. a Genotyping of P. falciparum Pf3D70087/N9 was performed using 
the procedure based on multiple and species‑specific repetitions of microsatellite sequences described by Su et al. in 1998. b Electropherogram 
showing nucleic acid alignment using SeqMan software and sequenced with primers BC5 and BC8. The CytB 3D7 P. falciparum genome sequence 
M76611 (PlasmoDB) was used as reference
Table 3 qPCR assay performance
The efficiency of each qPCR was calculated with the formula: 
Efficiency = −1 + 10(−1/slope) (http://www.thermoscientificbio.com/webtools/
qpcrefficiency/), which uses the slope produced by a qPCR standard curve. qPCR 
efficiency was validated by comparing the slope of the standard curve to the 
theoretical optimum of −3.32 which reflects 100 %
Gene Slope Y‑Inter R2 % Eff
P. falciparum
LDH −3.77 27.03 0.99 84.33
CytB −3.80 16.49 0.99 83.38
18S rRNA −3.56 5.69 0.99 90.92
P. yoelii
LDH −3.45 21.62 0.95 94.88
CytB −3.70 13.97 1.00 86.28
18S rRNA −3.73 16.65 0.99 85.49
P. berghe
LDH −4.27 23.30 0.96 71.43
CytB −5.64 22.53 0.92 50.46
18S rRNA −4.55 25.42 1.00 65.93
Table 4 Limit of detection (log10 parasites/µl)
Detection limit of log10 parasites/µl expressed as the median of the experiments 
(min–max)
Gene DNA frozen DNA FTA
P. falciparum
LDH 2.2 (1.1 to 3.2) 4.9 (4.5 to 5.2)
CytB 1.9 (1.1 to 2.6) 0.4 (−0.8 to 1.5)
18S rRNA 1.9 (0.1 to 3.6) 3.9 (2.5 to 5.2)
P. yoelii
LDH 0.8 (0.8 to 0.8) 2.2 (0.2 to 4.2)
CytB 2.8 (0.8 to 4.8) 1.5 (0.9 to 2.2)
18S rRNA 0.3 (−0.2 to 0.8) 1.2 (0.2 to 2.2)
P. berghei
LDH 0.9 (0.9 to 0.9) 1.8 (1.3 to 2.3)
CytB 0.9 (−0.1 to 1.9) 0.8 (0.3 to 1.3)
18S rRNA 0.4 (−1.1 to 1.9) 2.8 (2.3 to 3.3)
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Discussion
Determination of parasitaemia by flow cytometry is accu-
rate with a LOD of 0.0009 × 106 parasites/µl but has the 
limitation of sample storage, and although microscopy 
is still considered the gold standard, it has a reduced 
throughput. Detection of Plasmodium DNA by amplifi-
cation techniques based on PCR from dried blood on fil-
ter paper has been effectively used for sexual and asexual 
parasites even in studies conducted over decades [3, 9, 19, 
20]. Studies performed with filter paper stored over long 
time periods and under different conditions have shown 
variable results as regards sensitivity for parasite detection 
[21]. Moreover, previous cross-platform work and cross-
study comparisons already showed discrepancies on LOD 
in P. falciparum studies [22]. The study discussed here is 
the first to report use of filter paper with samples from 
mouse malaria models to support the early drug discov-
ery process. The advantage of using FTA cards for in vivo 
assays has been shown, as they allow for sample storage at 
RT even for long time. In the present study, after extended 
storage periods at RT, although the LOD range was lower 
than for newly generated cards, the DNA extracted was 
sufficient for qualitative parasite detection, thus providing 
an advantage for retrospective studies.
The preanalytical steps of qPCR, and mainly DNA 
extraction, are extremely important because the quality 
of the genetic material collected impacts all downstream 
activities. Previous studies investigated different methods 
to optimize DNA extraction from filter papers [23–25]. 
In this study, and optimal DNA quality was obtained 
using the in-column silica membrane-based method. The 
qPCR technique has some limitations as routine meth-
odology, including long sample processing, but was more 
sensitive than microscopy [10], powerful for detecting 
genes related to drug resistance, and amenable to parasite 
genotyping [2]. All these properties are critical in pre-
clinical settings where access to and analysis of the origi-
nal samples is crucial to identify potential drug failures.
Fig. 2 Plot of the Ct values obtained by qPCR with the CytB gene of samples processed directly after FTA embedding (no storage) or after storage 
for 52 months for P. yoelii and P. falciparum samples and for 26 months for P. berghei. Error bars correspond with the standard deviation of qPCR 
duplicates
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Malaria-specific qPCR is being increasingly used 
because of its high sensitivity, speciation, and quantifi-
cation of malaria parasites. In this study, although some 
qPCR efficiencies were slightly outside the desirable effi-
ciency range of 90–105 %, quantification of Plasmodium 
parasites through qPCR with complete specificity has 
been shown even for samples with very low parasite den-
sities using a set of primers for the most common ana-
lysed genes from murine Plasmodium species (P. berghei 
and P. yoelii) and the human pathogen studied in the 
humanized mouse model (P. falciparum).
Conclusions
This study has reported for the first time complete primer 
sets for parasite detection and quantification to be used 
in in vivo anti-malarial trials, and demonstrated the feasi-
bility of using filter paper to collect and store in vivo ani-
mal samples.
The results of this study suggest that FTA cards are a 
practical and cost-effective, reliable source of Plasmo-
dium DNA amenable to parasite detection and practical 
for studies of anti-malarial resistance genes and species 
identification. FTA cards require a low volume of sample 
and are easy to store over time. This technique represents 
a practicable tool for preclinical trials with anti-malarial 
drugs.
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